Pharmacometrics and the transition to model-based development.
Clin Pharmacol Ther
; 82(2): 137-42, 2007 Aug.
Article
em En
| MEDLINE
| ID: mdl-17632539
ABSTRACT
As the transition to model-based drug development continues, pharmacometric analysis will have an increasingly important role across the entire life cycle of drug discovery, development, regulatory approval, and commercialization. For this reason, pharmacometrics can--and should--have an integrating function in the transformation to model-based development. This essay describes an approach for formalizing the pharmacometrics process using the disciplines encompassed by enterprise engineering.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Farmacologia Clínica
/
Serviços de Informação sobre Medicamentos
/
Modelos Teóricos
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Clin Pharmacol Ther
Ano de publicação:
2007
Tipo de documento:
Article
País de afiliação:
Estados Unidos